Golda Hudes is a Rheumatology/Immunology physician affiliated with Montefiore Medical Center. OpenAlex indexes 84 publications with 1,149 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Montefiore Medical Park
1515 Blondell Avenue, Ste. 220
Bronx, NY 10461
Telephone
866-633-8255Registry record last updated 8 Jul 2007.
Clinical trials
- Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis
Sponsor: Montefiore Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- GlaxoSmithKline, LLC.Program year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
68.6%Corticosteroid30.9%Fluticasone Propionate61%Trelegy Ellipta12%Breo Ellipta10%Budesonide-Formoterol Fumarate5%Dulera4%Symbicort3%Arnuity Ellipta2%Mometasone Furoate2%Breztri Aerosphere1%Flunisolide1%Part D<11 patientsHistamine-1 Receptor Antagonist10.9%Azelastine Hcl84%Levocetirizine Dihydrochloride13%Cetirizine Hcl4%Part D<11 patients+ 9 more classes in this area
Dermatology
11.2%Interleukin-4 Receptor alpha Antagonist6.9%Dupixent Syringe56%Dupixent Pen44%Part D≥24 patientsCorticosteroid4%Triamcinolone Acetonide100%Part D≥57 patients+ 1 more class in this area
Metabolism & gastrointestinal
7.9%Corticosteroid6.1%Prednisone100%Part D≥86 patientsProton pump inhibitor0.9%Omeprazole61%Pantoprazole Sodium39%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Increased IgG4 Levels Are Associated with Severe Asthma and Chronic Sinusitis in an Inner City Population with Persistent Eosinophilia
Journal of Allergy and Clinical Immunology
2024 - BASELINE CHARACTERISTICS OF PATIENTS FROM THE UNITED STATES WITH CRSWNP IN THE AROMA GLOBAL REGISTRY
Annals of Allergy Asthma & Immunology
2024 - Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD
Respiratory Research
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Michelle Gong, MD
Montefiore Medical Center
Sheryl Haut, MD
Montefiore Medical Center
Andreas Kaubisch, MD
Montefiore Medical Center
Lewis Eisen, MD
Montefiore Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”